I frankly know nothing about patents and standards, but to me it seems a development. What I know is that those extensions and applocations have a cost, so it is a proper investment made by Fidia itself. That could mean they are really aiming to commercialization, maybe.
Surfing their site, also, I noticed they changed the English title of their January update, from "study regarding hair loss" to "Prof. Brotzu's hair loss remedy". It means nothing, but the Italian version is untouched. I can't remember the "old version", so I didn't notice if there were any changes at the body of their message. Maybe someone with good memory could check:
http://www.fidiapharma.com/en/news/prof-brotzu-s-hair-loss-remedy,3,115
Also, days ago I sent an email to Fidia (yes, not really the smartest move of them all) because I wanted a punctualization about some generic questions I made. Obviously, I only got a generic response, but they said to me that sperimentation was NOT already ended, and they decided to not give any infos until it will be finished. And that's because they care about the people who will use it for long time periods (mainly Androgenetic Alopecia people), and the results long-term shall not be any different than their sperimentation results. Who can blame them?
Many users here and even on italian forums said that they were having problems with stability, but since the beginning I always said: "Who Telogen Effluvium f*** told you they're having stability issues?"
The story of the stability was brought up regarding the Spatolotion group buy, when the users of the first group reported good results at the beginning who subsided 2 weeks after, and after making pressures, they convinced Spatolatore to analyze the lotions and found a stability problem on DGLA. Now is solved (dunno if he lied) and they are experimenting their fake-lotion. But that is spatolatore, not Fidia.